IL-17A neutralizing antibody attenuates eosinophilic meningitis caused by Angiostrongylus cantonensis by involving IL-17RA/Traf6/NF-κB signaling

被引:10
|
作者
Feng, Ying [1 ]
Zheng, Cunjing [2 ]
Zhou, Zongpu [1 ]
Xiong, Huihui [2 ]
Feng, Feng [3 ]
Xie, Fukang [2 ]
Wu, Zhong-dao [2 ,4 ]
机构
[1] South China Univ Technol, Med Sch, Guangzhou 510004, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Guangzhou 510080, Guangdong, Peoples R China
[4] Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
A; cantonensis; IL-17A neutralizing antibodies; Eosinophilic meningitis; IL-17RA/Traf6/NF-kappa B signaling pathway; ASTROCYTES PLAY; INHIBITION; BRAIN; IL-5; ACT1; ACTIVATION; ASTHMA;
D O I
10.1016/j.yexcr.2019.111554
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Angiostrongylus cantonensis (A. cantonensis) is a foodborne parasite that can invade the central nervous system (CNS), resulting in eosinophilic meningitis (EM). However, the mechanism by which A. cantonensis causes eosinophilic infiltration into CNS is not well understood. Methods: In this study eosinophilic infiltration into the CNS caused by A. cantonensis was assessed based on eosinophil counts and evaluation of interleukin (IL)-5 and -13 levels by real-time PCR in brain of Balb/c mice. The expression and activation of IL-17A, IL17 receptor (IL-17R A), and IL-17RC and the related signaling molecules nuclear factor (NF)-kappa B1, NF-kappa B2, NF-kappa B activator (Act)1, tumor necrosis factor receptor-associated factor (Traf)5, and Traf6 during A. cantonensis infection in brain tissue of Balb/c mice were examined by real-time, western blotting and immunofluroence. A. cantonensis-infected Balb/c mice were treated with IL-17A neutralizing antibody to evaluate the role of IL17A in eosinophil accumulation in the CNS. Results: Our results showed A. cantonensis infection caused eosinophil accumulation and alterations in IL-5 and -13 levels. The expression of IL-17A and -17RA, Act1, and Traf6 but not of IL-17RC and Traf5 was upregulated during infection; this was accompanied by NF-kappa B1 and -kappa B2 activation. Importantly, application of IL-17A neutralizing antibody attenuated eosinophil accumulation in CNS and reversed the changes in IL-5 and -13 expression caused by A. cantonensis infection. Additionally, IL-17RA and Traf6 levels decreased, which was accompanied by NF-kappa B inactivation. Conclusion: IL-17A plays an important role in EM caused by A. cantonensis, possibly through activation of NF-KB via the IL-17RA/Traf6 signaling pathway. These findings highlight the potential for using IL-17A neutralizing antibody as a therapeutic strategy for the treatment of EM.
引用
收藏
页数:7
相关论文
共 26 条
  • [11] YOD1/TRAF6 association balances p62-dependent IL-1 signaling to NF-κB
    Schimmack, Gisela
    schorpp, kenji
    Kutzner, Kerstin
    Gehring, Torben
    Brenke, Jara Kerstin
    Hadian, Kamyar
    Krappmann, Daniel
    ELIFE, 2017, 6
  • [12] Cornuside protects against ischemic stroke in rats by suppressing the IL-17F/TRAF6/NF-κB pathway via the brain-gut axis
    Yan, Chao
    Liu, Zhihao
    Xie, Waner
    Zhang, Ting
    Zhang, Jiyao
    Li, Guodong
    Xu, Xiaoyan
    Ye, Lei
    Gong, Jianwei
    EXPERIMENTAL NEUROLOGY, 2024, 373
  • [13] IL-17A deletion reduces sevoflurane-induced neurocognitive impairment in neonatal mice by inhibiting NF-κB signaling pathway
    Zhang, Qi
    Li, Yanan
    Yin, Chunping
    Gao, Mingyang
    Yu, Jiaxu
    Guo, Junfei
    Xian, Xiaohui
    Hou, Zhiyong
    Wang, Qiujun
    BIOENGINEERED, 2022, 13 (06) : 14562 - 14577
  • [14] IL-17A promotes the neuroinflammation and cognitive function in sevoflurane anesthetized aged rats via activation of NF-κB signaling pathway
    Zhan-yun Yang
    Chang-xiu Yuan
    BMC Anesthesiology, 18
  • [15] Requirement for both JAK-Mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-κB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells'
    Huang, Fei
    Kao, Cheng-Yuan
    Wachi, Shinichiro
    Thai, Philip
    Ryu, Jisu
    Wu, Reen
    JOURNAL OF IMMUNOLOGY, 2007, 179 (10): : 6504 - 6513
  • [16] IL-19 induced by IL-13/IL-17A in the nasal epithelium of patients with chronic rhinosinusitis upregulates MMP-9 expression via ERK/NF-κB signaling pathway
    Li, Xia
    Huang, Jiancong
    Chen, Xiaohong
    Lai, Xiaoping
    Huang, Zizhen
    Li, Yue
    Li, Shuaixiang
    Chang, Lihong
    Zhang, Gehua
    CLINICAL AND TRANSLATIONAL ALLERGY, 2021, 11 (01)
  • [17] IL-23/IL-17 immune axis mediates the imiquimod-induced psoriatic inflammation by activating ACT1/TRAF6/TAK1/NF-κB pathway in macrophages and keratinocytes
    Chen, Wen-Cheng
    Wen, Chang-Hui
    Wang, Meng
    Xiao, Zi-Dan
    Zhang, Zhong-Zhao
    Wu, Chun-Lan
    Wu, Ran
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2023, 39 (08): : 789 - 800
  • [18] Qingre Huayu Jianpi prescription alleviates the inflammatory transformation of colitis-associated colorectal cancer by inhibiting the IL-17RA/ACT1/NF-κB axis
    Duan, Yilin
    Lu, Yao
    Liu, Zhenglin
    Zhang, Jin
    Yang, Zhiyu
    Guo, Yihan
    Yang, Yi
    Lin, Wenjia
    Shuai, Yuxing
    Huang, Jiaying
    Xu, Yingjian
    Wu, Renxiong
    Wu, Yongqiang
    Li, Yanwu
    Ke, Junyu
    JOURNAL OF ETHNOPHARMACOLOGY, 2025, 345
  • [19] Minocycline reverses IL-17A/TRAF3IP2-mediated p38 MAPK/NF-κB/iNOS/NO-dependent cardiomyocyte contractile depression and death
    Yoshida, Tadashi
    Das, Nitin A.
    Carpenter, Andrea J.
    Izadpanah, Reza
    Kumar, Senthil A.
    Gautam, Sandeep
    Bender, Shawn B.
    Siebenlist, Ulrich
    Chandrasekar, Bysani
    CELLULAR SIGNALLING, 2020, 73
  • [20] miR-146a regulates the function of Th17 cell differentiation to modulate cervical cancer cell growth and apoptosis through NF-κB signaling by targeting TRAF6
    Li, Tian
    Li, Mengxiong
    Xu, Chengfang
    Xu, Xiaoyu
    Ding, Jie
    Cheng, Li
    Ou, Rongying
    ONCOLOGY REPORTS, 2019, 41 (05) : 2897 - 2908